You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LA-NSCLC

Showing 1 - 25 of 4,526
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, Non-small Cell Trial in Nanjing (hypofractionated radiation therapy)

Active, not recruiting
  • Lung Cancer, Non-small Cell
  • hypofractionated radiation therapy
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Mar 13, 2023

NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage III
  • radiotherapy
  • +3 more
  • (no location specified)
Sep 10, 2023

NSCLC Stage III, NSCLC Stage II Trial in China (Dose-Painting Radiation)

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • Non-small Cell Lung Cancer Stage II
  • Dose-Painting Radiation
  • Chengdu, Sichuan, China
  • +3 more
Sep 1, 2021

NSCLC, NSCLC Stage III, Recurrent Non Small Cell Lung Cancer Trial (Garmin Vivofit Activity Tracker)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Garmin Vivofit Activity Tracker
  • (no location specified)
Aug 31, 2022

NSCLC Metastatic Trial in La Jolla (Nivolumab + Plinabulin)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Nivolumab + Plinabulin
  • La Jolla, California
    UC San Diego Moores Cancer Center
Nov 21, 2022

NSCLC Stage II, NSCLC, Stage IIIA Trial in Goyang-si (Erlotinib)

Active, not recruiting
  • NSCLC Stage II
  • NSCLC, Stage IIIA
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Non-Small-Cell Lung Carcinoma Trial in France (Radiological Arm, Scannographic arm)

Completed
  • Non-Small-Cell Lung Carcinoma
  • Radiological Arm
  • Scannographic arm
  • Belfort, France
  • +6 more
Aug 9, 2022

NSCLC Trial in France, Spain (GB1211, Placebo, Atezolizumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • Dijon, France
  • +7 more
Sep 30, 2022

Metastatic Non Small Cell Lung Cancer, KRAS G12C Trial in Worldwide (Sotorasib, Lenvatinib)

Not yet recruiting
  • Metastatic Non Small Cell Lung Cancer
  • KRAS G12C
  • Innsbruck, Austria
  • +14 more
Sep 28, 2023

NSCLC, Stage III, ALK-rearrangement Trial in Worldwide (Brigatinib, Durvalumab)

Not yet recruiting
  • NSCLC, Stage III
  • ALK-rearrangement
  • Angers, France
  • +19 more
Feb 8, 2023

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023

Non Small Cell Lung Cancer Metastatic Trial in Worldwide (Osimertinib, Bevacizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer Metastatic
  • Dublin, Ireland
  • +24 more
Aug 23, 2022

NSCLC Trial in Spain, United Kingdom, United States (Lazertinib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Duarte, California
  • +8 more
Jan 31, 2023

Monitor Lung Cancer Patients Activity And Assess Performance

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Actigraphy device (wearable) and mobile application
  • Alcorcon, Madrid, Spain
  • +10 more
Jan 13, 2023

NSCLC Trial in United States (capmatinib)

Recruiting
  • Non-small Cell Lung Cancer
  • La Jolla, California
  • +7 more
Oct 5, 2022

Lung Cancer Trial in Spain (Pembrolizumab)

Recruiting
  • Lung Cancer
  • Elche, Alicante, Spain
  • +18 more
Jan 9, 2023

NSCLC, Pancoast Tumor Trial in Spain (Carboplatin, Paclitaxel, Nivolumab)

Not yet recruiting
  • NSCLC
  • Pancoast Tumor
  • Mataró, Barcelona, Spain
  • +28 more
Jan 13, 2023

Non Small Cell Lung Cancer Trial in Spain (Tipifarnib)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Santiago De Compostela, A Coruña, Spain
  • +29 more
Sep 21, 2022

ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC

Recruiting
  • Non Small Cell Lung Cancer Stage III
  • Neoadjuvant Treatment
    • Badalona, Barcelona, Spain
    • +19 more
    Jul 28, 2022

    Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) Trial in Worldwide (SAR408701 (Tusamitamab ravtansine), Pembrolizumab,

    Recruiting
    • Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)
    • SAR408701 (Tusamitamab ravtansine)
    • +4 more
    • Westwood, Kansas
    • +26 more
    Aug 11, 2022

    NSCLC, Stage IV, Oligometastasis Trial in Netherlands, Spain, Switzerland (drug, radiation, procedure)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • +2 more
    • Milano, Italy
    • +12 more
    Dec 14, 2022

    EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC Trial in Worldwide (Atezolizumab, Bevacizumab, Carboplatin)

    Active, not recruiting
    • EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
    • Großhansdorf, Germany
    • +17 more
    Jan 12, 2023

    Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +19 more
    • A2B694
    • xT CDx with HLA-LOH Assay
    • Duarte, California
    • +9 more
    Sep 22, 2023

    NSCLC Stage III, KRAS P.G12C Trial in Spain (Sotorasib)

    Recruiting
    • Non-small Cell Lung Cancer Stage III
    • KRAS P.G12C
    • Badalona, Barcelona, Spain
    • +19 more
    Jul 6, 2022

    Metastatic NSCLC Trial in France (Pembrolizumab before randomization, Chemotherapy, Pemetrexed)

    Recruiting
    • Metastatic NSCLC
    • Pembrolizumab before randomization
    • +3 more
    • Aix-en-Provence, France
    • +37 more
    Jul 26, 2022